Johnson & Johnson, Imerys ordered to pay additional US$80mln in punitive damages in talc-cancer case
A New Jersey state court jury awarded the damages today, the report says
Company
Johnson & Johnson
NYSE:JNJ
Johnson & Johnson is a diversified healthcare products company. The company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through two segments: Pharmaceutical and MedTech.
152 stories · page 6 of 8
Johnson & Johnson, Imerys ordered by court to pay at least US$37mln in asbestos suit
Investment banker claimed asbestos in talc product caused cancer
New tax law drags Johnson & Johnson’s fourth quarter into red territory but sales up
The new tax law saw the company make a provisional tax charge of US$13.27bn
Johnson & Johnson, Chesapeake Energy, Verizon Communications and more - PRE-MARKET
Wall Street shares are seen starting mixed - what else is happening in pre-market deals?
Hardware & electrical equipment
Abbott Laboratories, Apple Inc, Lennar and Wynn Resorts Ltd - PRE-MARKET
Proactive takes a look at pre-market trade in New York, and picks out some highlights
Nasdaq lower but Dow Jones and S&P 500 gain at close
US stocks were mixed at the close, with the Nasdaq in the red
Johnson & Johnson ups full year guidance after third quarter beats market expectations
In the third quarter, revenue from its largest unit, the pharmaceutical arm, surged 15%, boosted by the US$30bn acquisition of Swiss biotech Actelion earlier this year and new additions including Darzalex
Goldman Sachs Group, Morgan Stanley, Harley Davidson and more - PRE-MARKET
We take a look at what's moving the needle in pre-market deals in New York
Johnson & Johnson enjoys positive noises from analysts
Swiss bank UBS repeated a 'buy' on the shares, targeting $148, while Stifel says it's poised to accelerate growth in the second half.
Gilead Sciences, Kite Pharma, Amazon.com, Hurricane Harvey and more - PRE-MARKET
We look at what's coming up before the bell this week in New York trade
Goldman Sachs Group, Johnson & Johnson, Harley-Davidson and more
In pre-market trade, shares in motorcycle giant Harley-Davidson Inc dropped almost 9%
Johnson & Johnson shares advance as second quarter beats market expectations
Johnson & Johnson shares were changing hands at US$133.50 each, up 1%.
Johnson & Johnson may seek to set aside talc cancer judgements after Supreme Court ruling
Over 1,000 plaintiffs have sued J&J in the state of Missouri but most are from outside of the state.
ShareRoot shares ride higher on signing Johnson & Johnson
Global sales pipeline for the ShareRoot platform continues to strengthen.
GSK, AT&T and Verizon join advertising boycott on Google over extremist content
Google's promise to crack down on adverts from appearing alongside extremist content has failed to reassure clients
Aspiring to AAA seems as simple as ABC for Google owner Alphabet
Alphabet the owner of Google, now has a Standard & Poor’s credit rating on a par with the United States of America
US shares mark fresh record highs as banks price in earlier rate hike
US stocks marked a fresh raft of record highs on Wednesday as the Fed brought forward the prospect of rate hikes in the world’s biggest economy and bank stocks hit record highs
Johnson & Johnson nips ecological doomsday scenario in the (cotton) bud
Trending this morning: J&J abandons use of plastic in cotton buds; Valentine's Day; Rolls-Royce; Credit Suisse
AbbVie's revenue miss clouds strong Humira US sales
AbbVie Inc shares were lower on Friday after the pharma reported quarterly adjusted revenue that missed analysts' estimates as weaker-than-expected sales of its hepatitis C treatment and cancer therapy overshadowed strong US demand for its
US stocks close mixed after Trump mulls 20% border tax
US stocks closed mixed on Thursday, with the Dow and Nasdaq marking fresh record highs but the S&P 500 doing as much – before heading lower after US President Donald Trump mooted that he was weighing up a 20% border tax on Mexican imports t